Increase of hypophyseal hormone levels in male head and neck cancer patients

Pathology and Oncology Research

Volumn 13, Issue 4, 2007, Pages 341-344

  Remenár, Éva ^a   Számel, Irén ^a   Budai, Barna ^a   Vincze, Borbála ^a   Gaudi, István ^a   Gundy, Sarolta ^a   Kásler, Miklós ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Alcoholic liver disease; Head and neck cancer; Hypophysis hormones; Sex steroids

Indexed keywords

FOLLITROPIN; GAMMA GLUTAMYLTRANSFERASE; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; PRASTERONE; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HEAD AND NECK CANCER; HORMONE BLOOD LEVEL; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; OROPHARYNX CANCER; PROGNOSIS; SEX DIFFERENCE; SMOKING HABIT; SQUAMOUS CELL CARCINOMA;

EID: 39649095593     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02940314     Document Type: Article

References (27)

1. Tsugane S, Fahey MT, Sasaki S, Baba S: Alcohol consumption and all-cause and cancer mortality among middle-aged Japanese men: seven-year follow-up of the JPHC study cohort I. Japan Public Health Center. Am J Epidemiol 150: 1201-1207, 1999
2. Bray I, Brennan P, Boffetta P: Projections of alcohol- and tobacco-related cancer mortality in Central Europe. Int J Cancer 87: 122-128, 2000
3. Boffetta P, Ye W, Adami HO, Mucci LA, Nyren O: Risk of cancers of the lung, head and neck in patients hospitalized for alcoholism in Sweden. Br J Cancer 85: 678-682, 2001
4. World Health Organization: The tobacco atlas. Geneva; World Health Organization, 2002
5. Zeka A, Gore R, Kriebel D: Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control 14: 897-906, 2003
6. World Health Organization: Global status report on alcohol. Geneva; World Health Organization, 2004
7. Ezzati M, Henley SJ, Lopez AD, Thun MJ: Role of smoking in global and regional cancer epidemiology: Current patterns and data needs. Int J Cancer 116: 963-971, 2005
8. Boffetta P, Hashibe M: Alcohol and cancer. Lancet Oncol 7: 149-156, 2006
9. Bannister P, Losowsky MS: Sex hormones and chronic liver disease. J Hepatol 6: 258-262, 1988
10. Wang YJ, Wu JC, Lee SD, Tsai YT, Lo KJ: Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 38: 531-534, 1991
11. Martinez-Riera A, Santolaria-Fernandez F, Gonzalez Reimers E, Milena A, Gomez-Sirvent JL, Rodriguez-Moreno F, Gonzalez-Martin I, Rodriguez-Rodriguez E: Alcoholic hypogonadism: hormonal response to clomiphene. Alcohol 12: 581-587, 1995
12. Zietz B, Lock G, Plach B, Drobnik W, Grossmann J, Schölmerich J, Straub RH: Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol 15: 495-501, 2003
13. Patel JD, Bach PB, Kris MG: Lung cancer in US women. A contemporary epidemic. JAMA 291: 1763-1768, 2004
14. Yoo HJ, Sepkovic DW, Bradlow HL, Yu GP, Sirilian HV, Schantz SP: Estrogen metabolism as a risk factor for head and neck cancer. Otolaryngol Head Neck Surg 124: 241-247, 2001
15. Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y, Ogawa J: Estrogen receptor a and b are prognostic factors in non-small cell lung cancer. Clin Cancer Res 11: 5084-5089, 2005
16. Chan JA, Meyerhardt JA, Chan AT, Giovanucci EL, Colditz GA, Fuchs CS: Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol 24: 5680-5686, 2006
17. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G: Sex hormones and risk of liver tumor. Ann N Y Acad Sci 1089: 228-236, 2006
18. Poynard T, Aubert A, Bedossa P, Abella A, Naveau S, Paraf F, Chaput JC: A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 100: 1397-1402, 1991
19. Yokoyama A, Muramatsu T, Ohmori T, Yokoyama T, Okuyama K, Takahashi H, Hasegawa Y, Higuchi S, Maruyama K, Shirakura K, Ishii H: Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19: 1383-1387, 1998
20. Makimoto K, Higuchi S: Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men. Int J Epidemiol 28: 30-34, 1999
21. Duvoux C, Delacroix I, Richardet J-P, Roudot-Thoraval F, Métreau JM, Faqniez PL, Dhumeaux D, Cherqui D: Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 67: 418-421, 1999
22. Kopp MS, Rethelyi JC: Where psychology meets physiology: chronic stress and premature mortality - the Central-Eastern European health paradox. Brain Res Bull 62: 351-367, 2004
23. Lukits J, Remenár É, Rásó E, Ladányi A, Kásler M, Tímár J: Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. Int J Oncol 30:155-160, 2007
24. Chen SS, Chen KK, Lin AT, Chang YH, Wu HH, Chang LS: The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastases. BJU Int 89: 710-713, 2002
25. Bhatavdekar JM, Patel DD, Vora HH, Balar DB: Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol 14: 55-58, 1993
26. Bhatavdekar JM, Patel DD, Chikhlikar PR, Mehta RH, Vora HH, Karelia NH, Ghosh N, Shah NG, Suthar TP, Neema JP, et al: Levels of circulating peptide and steroid hormones in men with lung cancer. Neoplasma 41: 101-103, 1994
27. Bhatavdekar JM, Patel DD, Vora HH, Shah NG, Chikhlikar PR, Ghosh N: Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience. Head Neck 22: 257-264, 2000